Atossa Therapeutics ATOS
NASDAQ ATOS
$2.14 +0.01 (+0.47%)
At close: Nov 10, 2026 · 4:00 PM EST

Atossa Therapeutics (ATOS) Short term Debt (2011 - 2012)

Updated

Atossa Therapeutics' Short term Debt was $250,000 in Q3 2012.

Analysis

Atossa Therapeutics (ATOS) Short term Debt (2011 - 2012) Analysis & Trends

At the end of FY2011, Short term Debt at Atossa Therapeutics came in at $1 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Atossa Therapeutics 19.96 Mn -131.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 250,000.00
Dec 31, 2011 1.00 Mn
API Access

Atossa Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=ATOS&period=max&api_key=YOUR_API_KEY